## TER: Teradyne, Inc. - XLK: Technology

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 3.8% in lower entry zone (3.0-6.0%), top quartile (79th pct) cross-sectional ranking. Short-term MRS_5 (0.8%) confirms momentum alignment. Outperforming sector by 2.7%. Caution: momentum weakening (-4.9% MRS), overbought RSI (70).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($188.83)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 9, Bearish: 0)

**1. Is Teradyne Stock Outperforming the Nasdaq?**
- Source: Markets Financial Content | 20251210T080300 | Bullish | Relevance: 99%
-  Teradyne, Inc. (TER) is a leading global semiconductor company with a market cap of $31.8 billion, significantly outperforming the Nasdaq Composite recently due to AI-related demand. The company saw a 73.8% surge in its stock over the past three months and analysts have a "Moderate Buy" rating with potential upside. Strong Q3 performance, product innovation, and strategic investments in AI and robotics are key drivers of its growth.

**2. Teradyne Will Expand Its Global Robotics Presence with New US Operations Hub in Metro Detroit, Michigan**
- Source: Investing News Network | 20251209T160841 | Bullish | Relevance: 99%
-  Teradyne Robotics is establishing a new U.S. Operations Hub in Wixom, Metro Detroit, Michigan, set to open in 2026. This facility will manufacture Universal Robots' cobots and potentially MiR's AMRs, serving as a training and service center to cater to the growing manufacturing demands in the Americas. This strategic expansion aims to create over 200 jobs, enhance advanced manufacturing in the U.S., and support the re-industrialization of America through advanced robotics.

**3. Teradyne Surges 129% in Six Months: Is the Stock Worth a Buy?**
- Source: Finviz | 20251209T180838 | Bullish | Relevance: 99%
- Teradyne (TER) shares have surged 129.2% in the past six months, outperforming its sector and peers, driven by strong AI-related demand and an expanding portfolio in semiconductor testing and robotics. The company's innovative products like the ETS-800 D20 and UltraPHY 224G, coupled with its focus on AI-driven robotics, position it for continued growth, although its current valuation appears premium. Despite being overvalued based on Price/Sales, Zacks Investment Research recommends accumulating the stock due to its robust prospects.

**4. Here's How Much a $1000 Investment in Teradyne Made 10 Years Ago Would Be Worth Today**
- Source: Nasdaq | 20251210T130855 | Bullish | Relevance: 98%
-  This article details the hypothetical growth of a $1000 investment in Teradyne (TER) made ten years ago, calculating its current worth and comparing it to the S&P 500 and gold. It highlights Teradyne's business drivers, including automated test equipment and robotics, and discusses their market performance and future prospects driven by AI-related demand. The piece concludes with an analysis of analyst expectations for TER.

**5. Teradyne to establish U.S. operations hub in Metro Detroit**
- Source: The Fabricator | 20251210T201058 | Bullish | Relevance: 98%
- Teradyne Robotics will open a new U.S. operations hub in Wixom, Mich., (Metro Detroit) in 2026, creating more than 200 jobs. The facility will manufacture Universal Robots industrial cobots and potentially MiR autonomous mobile robots, serving as a regional customer training center, service hub, and visitor experience center.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-02 | Stifel | $225 | $162 | +39% |
| 2025-11-12 | Citigroup | $215 | $117 | +84% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-02 | Stifel | up | Buy |
| 2025-11-12 | Citigroup | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 7 ($0.08M) |
| Sells | 5 ($0.63M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 44.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 12.3% (+2.1%)
- Blackrock Inc.: 8.4% (-7.2%)
- JPMORGAN CHASE & CO: 5.4% (+126.5%)
- State Street Corpora: 4.0% (+0.3%)
- Ameriprise Financial: 3.0% (+6.8%)

### Key Risks

1. High beta (1.85) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.64 elevated, pricing in significant growth expectations. Forward P/E 39.9x attractive for 45% earnings growth. Quality metrics strong (margin 16%). Balance sheet: low leverage (D/E 0.46). Revenue growth strong at 23% YoY. Analyst sentiment positive (2 raises, avg +61%). Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $32.4B |
| Beta | 1.85 |
| 52W Range | $65.77 - $205.00 |
| Short Interest | 4.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.64 |
| Forward P/E | 39.9 |
| Current P/E | 58.0 |
| YoY Growth | 45.1% |
| EPS Direction | RISING |

### Technicals

MRS_10 deteriorating from 8.8% to 3.8% (-4.9% in 5 days), indicating relative weakness vs NASDAQ. Currently in lower STRENGTH zone (3.0-6.0%), cross-sectional ranking at 79th percentile. MRS_5 at 0.8% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.87), confirming momentum. RSI overbought at 70, risk of mean reversion.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 3.82% (CS: 79) | Strong |
| RSI_14 | 70.1 | Overbought |
| MACD Histogram | 1.87 | Bullish |
| vs SMA20 | 1.126x | Above |
| vs SMA50 | 1.228x | Above |
| vs SMA200 | 1.808x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $203.97
- **Stop Loss:** $188.83 (7.4% risk)
- **Target:** $226.68 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 91
- **Position Value:** $18,561.27
- **Portfolio %:** 18.56%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-01-28 (Est: $1.36)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.79 | $0.85 | +7.4% |
| 2025Q2 | $0.54 | $0.57 | +4.9% |
| 2025Q1 | $0.62 | $0.75 | +21.7% |
| 2024Q4 | $0.91 | $0.95 | +4.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*